On Nov 27, major Wall Street analysts update their ratings for $Bath & Body Works (BBWI.US)$, with price targets ranging from $34 to $52.
Morgan Stanley analyst Alexandra Straton maintains with a buy rating, and maintains the target price at $49.
Goldman Sachs analyst Kate McShane maintains with a buy rating, and adjusts the target price from $49 to $52.
Citi analyst Paul Lejuez maintains with a hold rating, and adjusts the target price from $35 to $40.
Barclays analyst Adrienne Yih maintains with a sell rating, and adjusts the target price from $28 to $34.
UBS analyst Jay Sole maintains with a hold rating, and adjusts the target price from $38 to $40.
Furthermore, according to the comprehensive report, the opinions of $Bath & Body Works (BBWI.US)$'s main analysts recently are as follows:
Bath & Body Works reported Q3 results that met expectations, and the management has increased its Q4 earnings forecast by 2% at the midpoint.
Following the Q3 report where Bath & Body Works delivered an unexpected topline upside due to core product strength, and subsequently raised fiscal year guidance, there is increased conviction in the company's capacity to sustain at least low-single digit percentage growth steadily over time.
Bath & Body Works reported its strongest sales growth in 10 quarters during Q3. With an upturn in sales and well-managed margins, the prospects for revaluation of the stock's multiple are increasing, positioning it as a compelling investment idea for 2025.
Bath & Body Works reported Q3 results that exceeded expectations in both sales and earnings, though there was a shortfall in gross margins attributed to increased promotional activity. These promotions, however, were effective in stimulating sales. The company has also raised its fiscal 2024 forecasts for sales and earnings, following the strong performance in Q3 and sustained momentum heading into Q4.
The firm observed that Bath & Body Works demonstrated widespread strength, attributed to modest anticipation preceding earnings and a raise in the FY24 guidance.
Here are the latest investment ratings and price targets for $Bath & Body Works (BBWI.US)$ from 8 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間11月27日，多家華爾街大行更新了$Bath & Body Works (BBWI.US)$的評級，目標價介於34美元至52美元。
摩根士丹利分析師Alexandra Straton維持買入評級，維持目標價49美元。
高盛集團分析師Kate McShane維持買入評級，並將目標價從49美元上調至52美元。
花旗分析師Paul Lejuez維持持有評級，並將目標價從35美元上調至40美元。
巴克萊銀行分析師Adrienne Yih維持賣出評級，並將目標價從28美元上調至34美元。
瑞士銀行分析師Jay Sole維持持有評級，並將目標價從38美元上調至40美元。
此外，綜合報道，$Bath & Body Works (BBWI.US)$近期主要分析師觀點如下：
巴斯與體香有趣公司報告的第三季度業績符合預期，管理層將第四季度的盈利預測中點提高了2%。
在第三季度報告中，巴斯與體香有趣公司因核心產品的強勁表現而出現了意想不到的銷售增長，隨後提高了財政年度指引，增加了對公司能夠穩定維持至少低個位數百分比增長的信心。
巴斯與體香有趣公司在第三季度報告了10個季度以來最強勁的銷售增長。隨着銷售的回升和良好的利潤管理，該股票的重新估值前景正在增加，使其成爲2025年的一個引人注目的投資想法。
巴斯與體香有趣公司報告的第三季度業績在銷售和盈利方面都超出了預期，但由於促銷活動增加，毛利率有所下降。然而，這些促銷在刺激銷售方面是有效的。公司還在第三季度表現強勁以及第四季度保持勢頭的情況下，提升了2024財政年度的銷售和盈利預測。
該公司觀察到巴斯與體香有趣公司展現出廣泛的強勁表現，這歸因於盈利前的適度預期和對2024財年的指導提高。
以下爲今日8位分析師對$Bath & Body Works (BBWI.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
